- Home
- TRVI vs AVAH Comparison
TRVI vs AVAH Comparison
Compare TRVI & AVAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- AVAH
- Stock Information
- Founded
- TRVI 2011
- AVAH 1984
- Country
- TRVI United States
- AVAH United States
- Employees
- TRVI N/A
- AVAH N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- AVAH Hospital/Nursing Management
- Sector
- TRVI Health Care
- AVAH Health Care
- Exchange
- TRVI Nasdaq
- AVAH Nasdaq
- Market Cap
- TRVI 1.1B
- AVAH 872.6M
- IPO Year
- TRVI 2019
- AVAH 2021
- Fundamental
- Price
- TRVI $9.64
- AVAH $8.49
- Analyst Decision
- TRVI Strong Buy
- AVAH Buy
- Analyst Count
- TRVI 9
- AVAH 6
- Target Price
- TRVI $20.72
- AVAH $7.92
- AVG Volume (30 Days)
- TRVI 2.6M
- AVAH 1.3M
- Earning Date
- TRVI 11-05-2025
- AVAH 11-06-2025
- Dividend Yield
- TRVI N/A
- AVAH N/A
- EPS Growth
- TRVI N/A
- AVAH N/A
- EPS
- TRVI N/A
- AVAH 0.09
- Revenue
- TRVI N/A
- AVAH $2,177,672,000.00
- Revenue This Year
- TRVI N/A
- AVAH $16.37
- Revenue Next Year
- TRVI N/A
- AVAH $6.62
- P/E Ratio
- TRVI N/A
- AVAH $89.92
- Revenue Growth
- TRVI N/A
- AVAH 11.54
- 52 Week Low
- TRVI $2.36
- AVAH $3.67
- 52 Week High
- TRVI $10.16
- AVAH $9.03
- Technical
- Relative Strength Index (RSI)
- TRVI 64.43
- AVAH 58.65
- Support Level
- TRVI $8.24
- AVAH $8.38
- Resistance Level
- TRVI $8.65
- AVAH $8.95
- Average True Range (ATR)
- TRVI 0.51
- AVAH 0.35
- MACD
- TRVI 0.10
- AVAH -0.08
- Stochastic Oscillator
- TRVI 76.06
- AVAH 55.05
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About AVAH Aveanna Healthcare Holdings Inc.
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). Private Duty Services include private duty nursing (PDN) and pediatric therapy services. Revenue is derived from pediatric healthcare services provided to patients including private duty nursing and therapy services, adult home health and hospice services (collectively patient revenue) and from the delivery of enteral nutrition and other products to patients.